Novel drug therapies for cardiac amyloidosis

Prakash Harikrishnan, Srikanth Yandrapalli, Wilbert S. Aronow, Gregg M. Lanier, Diwakar Jain

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)497-499
Number of pages3
JournalExpert Opinion on Investigational Drugs
Volume28
Issue number6
DOIs
StatePublished - Jun 3 2019
Externally publishedYes

Keywords

  • Cardiac amyloidosis
  • cardiomyopathy
  • drugs
  • light chain
  • transthyretin

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Harikrishnan, P., Yandrapalli, S., Aronow, W. S., Lanier, G. M., & Jain, D. (2019). Novel drug therapies for cardiac amyloidosis. Expert Opinion on Investigational Drugs, 28(6), 497-499. https://doi.org/10.1080/13543784.2019.1619695

Novel drug therapies for cardiac amyloidosis. / Harikrishnan, Prakash; Yandrapalli, Srikanth; Aronow, Wilbert S.; Lanier, Gregg M.; Jain, Diwakar.

In: Expert Opinion on Investigational Drugs, Vol. 28, No. 6, 03.06.2019, p. 497-499.

Research output: Contribution to journalEditorial

Harikrishnan, P, Yandrapalli, S, Aronow, WS, Lanier, GM & Jain, D 2019, 'Novel drug therapies for cardiac amyloidosis', Expert Opinion on Investigational Drugs, vol. 28, no. 6, pp. 497-499. https://doi.org/10.1080/13543784.2019.1619695
Harikrishnan P, Yandrapalli S, Aronow WS, Lanier GM, Jain D. Novel drug therapies for cardiac amyloidosis. Expert Opinion on Investigational Drugs. 2019 Jun 3;28(6):497-499. https://doi.org/10.1080/13543784.2019.1619695
Harikrishnan, Prakash ; Yandrapalli, Srikanth ; Aronow, Wilbert S. ; Lanier, Gregg M. ; Jain, Diwakar. / Novel drug therapies for cardiac amyloidosis. In: Expert Opinion on Investigational Drugs. 2019 ; Vol. 28, No. 6. pp. 497-499.
@article{201986db8a6144d39caa168fb50a52a4,
title = "Novel drug therapies for cardiac amyloidosis",
keywords = "Cardiac amyloidosis, cardiomyopathy, drugs, light chain, transthyretin",
author = "Prakash Harikrishnan and Srikanth Yandrapalli and Aronow, {Wilbert S.} and Lanier, {Gregg M.} and Diwakar Jain",
year = "2019",
month = "6",
day = "3",
doi = "10.1080/13543784.2019.1619695",
language = "English (US)",
volume = "28",
pages = "497--499",
journal = "Expert Opinion on Investigational Drugs",
issn = "1354-3784",
publisher = "Taylor and Francis Ltd.",
number = "6",

}

TY - JOUR

T1 - Novel drug therapies for cardiac amyloidosis

AU - Harikrishnan, Prakash

AU - Yandrapalli, Srikanth

AU - Aronow, Wilbert S.

AU - Lanier, Gregg M.

AU - Jain, Diwakar

PY - 2019/6/3

Y1 - 2019/6/3

KW - Cardiac amyloidosis

KW - cardiomyopathy

KW - drugs

KW - light chain

KW - transthyretin

UR - http://www.scopus.com/inward/record.url?scp=85066910175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066910175&partnerID=8YFLogxK

U2 - 10.1080/13543784.2019.1619695

DO - 10.1080/13543784.2019.1619695

M3 - Editorial

C2 - 31084448

AN - SCOPUS:85066910175

VL - 28

SP - 497

EP - 499

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

SN - 1354-3784

IS - 6

ER -